Healthcare -
Biotechnology - NASDAQ - US
$ 0.757
-0.264 %
$ 41.7 M
Market Cap
-0.43
P/E
PRLD - NET INCOME
Net Income PRLD - Prelude Therapeutics Incorporated
-122 M
LAST VALUE
-4.44%
2 YEAR CAGR
-52.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR